IQVIA Holdings Net Long-Term Debt 2011-2024 | IQV
IQVIA Holdings annual/quarterly net long-term debt history and growth rate from 2011 to 2024. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
- IQVIA Holdings net long-term debt for the quarter ending December 31, 2024 was $-0.172B, a 115.26% decline year-over-year.
- IQVIA Holdings net long-term debt for the twelve months ending December 31, 2024 was $-0.431B, a 112.7% decline year-over-year.
- IQVIA Holdings annual net long-term debt for 2024 was $-0.172B, a 115.26% decline from 2023.
- IQVIA Holdings annual net long-term debt for 2023 was $1.127B, a 82.95% increase from 2022.
- IQVIA Holdings annual net long-term debt for 2022 was $0.616B, a 540% decline from 2021.
| IQVIA Holdings Annual Net Long-Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $-172 |
| 2023 | $1,127 |
| 2022 | $616 |
| 2021 | $-140 |
| 2020 | $727 |
| 2019 | $1,001 |
| 2018 | $899 |
| 2017 | $2,357 |
| 2016 | $-1,485 |
| 2015 | $188 |
| 2014 | $242 |
| 2013 | $-388 |
| 2012 | $440 |
| 2011 | $260 |
| 2010 | $-78 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $27.061B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||